Calithera Biosciences, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Calithera Biosciences, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2022.
  • Calithera Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $1.14M, a 88.1% decline year-over-year.
  • Calithera Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.66M, a 9.5% decline from 2021.
  • Calithera Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $10.7M, a 74.6% decline from 2020.
  • Calithera Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $42.1M, a 57.5% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.14M -$8.4M -88.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $9.54M +$1.88M +24.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $7.66M +$6.51M +564% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $1.15M +$1M +669% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $150K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.